What is Bronchopulmonary Dysplasia (BPD)

Bronchopulmonary Dysplasia (BPD) is a chronic lung disease that primarily affects premature infants who have received prolonged mechanical ventilation or oxygen therapy. It occurs when the delicate tissues and airways in the lungs are damaged, leading to inflammation and scarring.

BPD commonly develops in infants born before 28 weeks of gestation or with very low birth weights. The main cause is the immaturity of the lungs, which are not fully developed at birth. Factors such as infections, exposure to high levels of oxygen, and lung injury from mechanical ventilation can further contribute to the development of BPD.

Infants with BPD may experience symptoms like rapid breathing, wheezing, coughing, and difficulty feeding. The severity of the condition can vary, with some infants requiring long-term respiratory support.

Treatment for BPD focuses on providing supportive care to improve lung function and manage symptoms. This may involve oxygen therapy, medications to reduce inflammation, and respiratory therapies. Close monitoring and follow-up care are essential to ensure the infant's lung function improves over time.